column
Accelerating Cervical Cancer Prevention and Control in China to Achieve Cervical Cancer Elimination Strategy Objectives
Linhong Wang
2022, 4(48): 1067-1069. DOI: 10.46234/ccdcw2022.215
Abstract FullText HTML PDF
Trends in Incidence Rates, Mortality Rates, and Age-Period-Cohort Effects of Cervical Cancer — China, 2003–2017
Kexin Sun, Rongshou Zheng, Lin Lei, Siwei Zhang, Hongmei Zeng, Shaoming Wang, Li Li, Ru Chen, Bingfeng Han, Ji Peng, Wenqiang Wei, Jie He
2022, 4(48): 1070-1076. DOI: 10.46234/ccdcw2022.216
Abstract FullText HTML PDF
Cervical Cancer Screening Coverage — China, 2018–2019
Mei Zhang, Yijing Zhong, Limin Wang, Heling Bao, Zhengjing Huang, Zhenping Zhao, Xiao Zhang, Chun Li, Kelly Liang Sun, Jing Wu, Xiaoying Zheng, Linhong Wang
2022, 4(48): 1077-1082. DOI: 10.46234/ccdcw2022.217
Abstract FullText HTML PDF
Prevalence of High-Risk Human Papillomavirus in Cervical Intraepithelial Neoplasia in the Pre-Vaccine Era — China, 2017–2018
Heling Bao, Weihong Chen, Xiaosong Zhang, Hui Bi, Yun Zhao, Liwen Fang, Shu Cong, Feng Tan, Linhong Wang
2022, 4(48): 1083-1087. DOI: 10.46234/ccdcw2022.218
Abstract FullText HTML PDF
Prevalence of High-Risk Human Papillomavirus by Subtypes Among Rural Women Aged 35–64 Years — Guangzhou City, Guangdong Province, China, 2019–2021
Dantong Shao, Xiaoyan Xia, Huihui Liu, Mingxi Huang, Jia Yu, Jianrong He, Xiu Qiu
2022, 4(48): 1088-1091. DOI: 10.46234/ccdcw2022.219
Abstract FullText HTML PDF